David Bachman to Methylphenidate
This is a "connection" page, showing publications David Bachman has written about Methylphenidate.
Connection Strength
0.307
-
Effect of methylphenidate on attention in apathetic AD patients in a randomized, placebo-controlled trial. Int Psychogeriatr. 2014 Feb; 26(2):239-46.
Score: 0.105
-
Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial. J Clin Psychiatry. 2013 Aug; 74(8):810-6.
Score: 0.103
-
Designing a trial to evaluate potential treatments for apathy in dementia: the apathy in dementia methylphenidate trial (ADMET). Am J Geriatr Psychiatry. 2013 Jun; 21(6):549-59.
Score: 0.099